JPRN-UMIN000044945已完成未知
Establishing a pharmacy pharmacist intervention program and assessing clinical outcomes for patients with dyslipidemia - Health improvement effect of pharmacy pharmacists for patients with dyslipidemia
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 35years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Familial Hypercholesterolemia 2)History of coronary artery disease 3)Diabetes,chronic kidney disease (CKD),noncardiogenic cerebral infarction,peripheral arterial disease (PAD) 4) Taking medicine for dementia / mental illness 5) Have serious illness including dialysis 6) Intervention less than 3 times in 8 months 7) Blood biochemical test values (LDL-C, HDL-C, TG) cannot be confirmed 8) Those who are judged to be unsuitable for research
研究者
相似试验
尚未招募
1 期
The role of pharmacist for enhancing medication adherence in COPD (Chronic Obstructive Pulmonary Diseases) patients in pakistaChronic Obstructive Pulmonary Disease (COPD).Chronic obstructive pulmonary disease, unspecifiedJ44.9IRCT20220516054875N1Quaid-i-Azam University , Islamabad150
尚未招募
不适用
A combined, tailored pharmacist intervention with dose optimization of phosphate binding drugs to improve phosphate control in patients on dialysis.NL-OMON24286Franciscus Gasthuis and Vlietland45
已完成
不适用
Pharmacist service to reduce side effects of medicines in older people in aged careCognitive functionPhysical functionFrailtyAdverse eventsPublic Health - Health service researchACTRN12618000766213Australian Government Department of Health Pharmacy Trial Program275
已完成
不适用
Effectiveness of a pharmacist intervention in patients with lung diseaseChronic Obstructive Pulmonary Disease (COPD)RespiratoryChronic obstructive pulmonary disease, unspecifiedISRCTN32281812The Health Research Foundation200
已完成
不适用
A pharmacist-led medicines review intervention in community-dwelling Maori older adults– a feasibility study.ACTRN12619001070123School of Pharmacy, University of Auckland17